An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Enrolling by invitation · NCT07459660 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis | Alzheimer disease, Hallucinations, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, perceptual disorders, psychiatric disorder, tauopathy | Enrolling by invitation | Phase 2 | 2026-08-07 | NCT07459660 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MapLight Therapeutics | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||